Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press20710.17650/1726-9776-2013-9-1-82-86CLINICAL CASEКЛИНИЧЕСКИЙ СЛУЧАЙPHYLLOIDES TUMOR OF THE PROSTATE: A REVIEW OF LITERATURE AND A CASE REPORTЛИСТОВИДНАЯ ОПУХОЛЬ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ: ОБЗОР ЛИТЕРАТУРЫ И ОПИСАНИЕ СЛУЧАЯPoddubskayaE. V.ПоддубскаяЕ. В.
Russian Federation
olga100va@yandex.ruSotnikovaO. P.СотниковаО. П.
Russian Federation
olga100va@yandex.ruKovalenkoI. P.КоваленкоИ. П.
Russian Federation
olga100va@yandex.ruKomovD. V.КомовД. В.
Russian Federation
olga100va@yandex.ruN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowФГБУ «РОНЦ им. Н.Н. Блохина» РАМН, Москва300320139182860108201401082014https://oncourology.abvpress.ru/oncur/article/view/207

Phyllodes tumor of the prostate is a rare neoplasm with poorly understood pathogenesis. Histologically, it resembles phyllodes tumor of the breast with hyperplastic epithelium lined cysts and channels embedded in a variably cellular stroma. A variety of terms have been used to describe these lesions, including phyllodes type of atypical hyperplasia, cystosarcoma phyllodes. The malignant potential of this tumor is unclear and has resulted in confusion in terms of prognosis and treatment.

Листовидная опухоль предстательной железы является редким новообразованием с плохо изученным патогенезом. Гистологическая структура ее напоминает строение листовидной опухоли молочной железы, что выражается в гиперплазии эпителия и каналов ткани железы. Существует множество терминов для описания этой патологии, например атипическая гиперплазия  филлоидного типа, филлоидная цистосаркома. Злокачественный потенциал этой опухоли не ясен и затрудняет прогноз и лечение.

phyllodes tumorprostatepathogenesisлистовидная опухольпредстательная железапатогенез1. McCarthy R.P., Zhang S., Bostwick D.G. et al. Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate. Am J Pathol 2004;165(4):56–72.McCarthy R.P., Zhang S., Bostwick D.G. et al. Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate. Am J Pathol 2004;165(4):56–72.2. Reese J.H., Lombard C.M., Krone K., Stamey T.A. Phyllodes type of atypical prostatic hyperplasia: a report of 3 new cases J Urology1987;138:623–6.Reese J.H., Lombard C.M., Krone K., Stamey T.A. Phyllodes type of atypical prostatic hyperplasia: a report of 3 new cases J Urology1987;138:623–6.3. Attah E.B., Nkposong E.O. Phyllodes type of atypical prostatic hyperplasia. J Urology1976;15:762 –4.Attah E.B., Nkposong E.O. Phyllodes type of atypical prostatic hyperplasia. J Urology1976;15:762 –4.4. Watanabe M., Yamada Y., Kato H. et al. Malignant phyllodes tumor of the prostate: retrospective review of specimens obtained by sequential transurethral resection. Pathol Int 2002;52:777–83.Watanabe M., Yamada Y., Kato H. et al. Malignant phyllodes tumor of the prostate: retrospective review of specimens obtained by sequential transurethral resection. Pathol Int 2002;52:777–83.5. Bostwick D.G., Hossain D., Qian J. et al. Phyllodes tumor of the prostate: long-term followup study of 23 cases. J Urology 2004;172:894–9.Bostwick D.G., Hossain D., Qian J. et al. Phyllodes tumor of the prostate: long-term followup study of 23 cases. J Urology 2004;172:894–9.6. Cheng L., Song S.Y., Pretlow T.G. et al. Evidence of independent origin of multiple tumors from patients with prostate cancer. J Nat Canc Institute 1998;90:233–7.Cheng L., Song S.Y., Pretlow T.G. et al. Evidence of independent origin of multiple tumors from patients with prostate cancer. J Nat Canc Institute 1998;90:233–7.7. Brandli D.W., Ulbright T.M., Foster R.C. et al. Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumor is derived from the same progenitor cells as the teratoma. Cancer Reserch 2003;63:6063–8.Brandli D.W., Ulbright T.M., Foster R.C. et al. Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumor is derived from the same progenitor cells as the teratoma. Cancer Reserch 2003;63:6063–8.8. Emmert-Buck M.R., Vocke C.D., Pozzatti R.O. et al. Allelic loss on chromosome 8p12–21 in microdissected prostatic intraepithelial.Neoplasia Canc Res 1995;55:2959–62.Emmert-Buck M.R., Vocke C.D., Pozzatti R.O. et al. Allelic loss on chromosome 8p12–21 in microdissected prostatic intraepithelial.Neoplasia Canc Res 1995;55:2959–62.9. Vocke C.D., Pozzatti R.O., Bostwick D.G. et al. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12–21. Cancer Reserch 1996;56:2411–6.Vocke C.D., Pozzatti R.O., Bostwick D.G. et al. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12–21. Cancer Reserch 1996;56:2411–6.10. Cheng L., Leibovich B.C., Bergstralh E.J. et al. p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression? Cancer 1999; 85:2455–9.Cheng L., Leibovich B.C., Bergstralh E.J. et al. p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression? Cancer 1999; 85:2455–9.11. Isaacs J.T., Lundmo P.I., Berges R. et al. Androgen regulation of programmed death of normal and malignant prostatic cells. J Andrology 1992;13:457–64.Isaacs J.T., Lundmo P.I., Berges R. et al. Androgen regulation of programmed death of normal and malignant prostatic cells. J Andrology 1992;13:457–64.12. Wang X., Jones T.D., Zhang S. et al. Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate. Modern Pathology 2007;20:175–82.Wang X., Jones T.D., Zhang S. et al. Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate. Modern Pathology 2007;20:175–82.13. Kersting C., Kuijper A., Schmidt H. et al. Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression. Laboratory Investigation 2006;86:54–61.Kersting C., Kuijper A., Schmidt H. et al. Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression. Laboratory Investigation 2006;86:54–61.14. Tan P.H., Jayabaskar T., Yip G. et al. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Modern Pathology 2005;18:1527–34.Tan P.H., Jayabaskar T., Yip G. et al. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Modern Pathology 2005;18:1527–34.15. Eble J.N., Sauter G., Epstein J.I. et al. World Health Organization Classification of Tumours: pathology and genetics of tumours of the urinary system and male genital organs. IARC Press 2004;21:36.Eble J.N., Sauter G., Epstein J.I. et al. World Health Organization Classification of Tumours: pathology and genetics of tumours of the urinary system and male genital organs. IARC Press 2004;21:36.16. Herawi M., Epstein J.I. Specialized stromal tumors of the prostate: a clinicopathologic study of 50 cases. Am J Surg Path 2006;30:694–704.Herawi M., Epstein J.I. Specialized stromal tumors of the prostate: a clinicopathologic study of 50 cases. Am J Surg Path 2006;30:694–704.17. Bhat D.M., Poflee S.V., Kotwal M.N. et al. Giant cystosarcoma phyllodes tumor of prostate: Case report of a rare entity. Indian J Cancer 2004;41:33.Bhat D.M., Poflee S.V., Kotwal M.N. et al. Giant cystosarcoma phyllodes tumor of prostate: Case report of a rare entity. Indian J Cancer 2004;41:33.18. Pins M.R., Campbell S.C., Laskin W.B. et al. Solitory fibrous tumor of the prostate. A report of 2 cases and review of the literature. Arch Pathology Lab Med 2001;125:274–7.Pins M.R., Campbell S.C., Laskin W.B. et al. Solitory fibrous tumor of the prostate. A report of 2 cases and review of the literature. Arch Pathology Lab Med 2001;125:274–7.19. Yamamato S., Ito I., Miki M et al. Malignant phyllodes tumor of the prostate. Int J Urol 2000;7:378–82.Yamamato S., Ito I., Miki M et al. Malignant phyllodes tumor of the prostate. Int J Urol 2000;7:378–82.